Cancer treatments often cause nerve damage that can lead to long-lasting symptoms. Medication has proven ineffective in these cases.
Layoffs at Ginkgo and Xellia; Melodia and Alivexis ink $275M partnership
Plus, news about Rapafusyn Pharmaceuticals: Ginkgo Bioworks lays off 158 employees: The cuts come after the Boston, MA-based biotech said last month … Sign up